{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:03:00Z","timestamp":1774436580147,"version":"3.50.1"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:p>The heterogeneous presentation of hidradenitis suppurativa (HS) lesions can result in variation in clinical trial outcome assessments when performed by the same rater as well as different raters. In the PIONEER I and II trials of patients with HS, there was substantial disagreement between repeated lesion counts by the same rater during a time period in which little true change is expected. Standardization of lesion classification and improved rater training are critical for advancing HS drug development.<\/jats:p>","DOI":"10.1093\/bjd\/ljae379","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T23:05:57Z","timestamp":1728342357000},"page":"535-537","source":"Crossref","is-referenced-by-count":3,"title":["Intra-rater agreement of lesion counts in hidradenitis suppurativa"],"prefix":"10.1093","volume":"192","author":[{"given":"Bria","family":"Midgette","sequence":"first","affiliation":[{"name":"Northwell , New Hyde Park, NY ,","place":["USA"]},{"name":"Department of Dermatology, Donald & Barbara Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[{"name":"Northwell , New Hyde Park, NY ,","place":["USA"]},{"name":"Department of Dermatology, Donald & Barbara Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-6856","authenticated-orcid":false,"given":"Amit","family":"Garg","sequence":"additional","affiliation":[{"name":"Northwell , New Hyde Park, NY ,","place":["USA"]},{"name":"Department of Dermatology, Donald & Barbara Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"2025021810040997800_ljae379-B1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/bjd\/ljad375","article-title":"Addressing high placebo response rates in randomized clinical trials for hidradenitis suppurativa","volume":"190","author":"Garg","year":"2024","journal-title":"Br J Dermatol"},{"key":"2025021810040997800_ljae379-B2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"2025021810040997800_ljae379-B3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/bmj.313.7059.744","article-title":"Measurement error","volume":"313","author":"Bland","year":"1996","journal-title":"BMJ"},{"key":"2025021810040997800_ljae379-B4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/bmj.313.7049.106","article-title":"Measurement error proportional to the mean [published correction appears in BMJ 1996 Sep 21; 313:744]","volume":"313","author":"Bland","year":"1996","journal-title":"BMJ"},{"key":"2025021810040997800_ljae379-B5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/jdv.15163","article-title":"Reliability of the Hidradenitis Suppurativa Clinical Response in the assessment of patients with hidradenitis suppurativa","volume":"32","author":"Kimball","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025021810040997800_ljae379-B6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jclinepi.2005.10.015","article-title":"When to use agreement versus reliability measures","volume":"59","author":"de Vet","year":"2006","journal-title":"J Clin Epidemiol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae379\/60475889\/ljae379.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/3\/535\/60475889\/ljae379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/3\/535\/60475889\/ljae379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:04:19Z","timestamp":1739873059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/3\/535\/7815060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,7]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae379","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,10,7]]}}}